A plasma 5-marker host biosignature identifies tuberculosis in high and low endemic countries BH Chendi, CI Snyders, K Tonby, S Jenum, M Kidd, G Walzl, NN Chegou, ... Frontiers in immunology 12, 608846, 2021 | 21 | 2021 |
Rate of viral load change and adherence of HIV adult patients treated with Efavirenz or Nevirapine antiretroviral regimens at 24 and 48 weeks in Yaoundé, Cameroon: a … BH Chendi, MC Okomo Assoumou, GB Jacobs, EL Yekwa, E Lyonga, ... BMC infectious diseases 19, 1-8, 2019 | 21 | 2019 |
Cytokine profile in the sputum of subjects with post-tuberculosis airflow obstruction and in those with tobacco related chronic obstructive pulmonary disease E Guiedem, EW Pefura-Yone, GM Ikomey, CN Nkenfou, M Mesembe, ... BMC immunology 21, 1-11, 2020 | 11 | 2020 |
CCL1 and IL-2Ra differentiate Tuberculosis disease from latent infection Irrespective of HIV infection in low TB burden countries BH Chendi, H Tveiten, CI Snyders, K Tonby, S Jenum, SD Nielsen, ... Journal of Infection 83 (4), 433-443, 2021 | 6 | 2021 |
Utility of a three-gene transcriptomic signature in the diagnosis of tuberculosis in a low-endemic hospital setting BH Chendi, T Jooste, TJ Scriba, M Kidd, S Mendelsohn, K Tonby, G Walzl, ... Infectious Diseases 55 (1), 44-54, 2023 | 2 | 2023 |
Potential implications of the climate crisis on diagnostics B Owusu Agyare, P Eder, S Shenai, BH Chendi, C Carlson, A Iradukunda, ... PLOS Global Public Health 4 (3), e0002935, 2024 | | 2024 |
PA-347 Diagnostic accuracy of published host blood transcriptomic tuberculosis signatures in a low burden hospital setting CB Hycenta, V Muwanga, T Jooste, M Kidd, SC Mendelsohn, G Walzl, ... BMJ Global Health 8 (Suppl 10), 2023 | | 2023 |
PA-511 Utility of host transcriptomic biomarkers in the diagnosis of spinal tuberculosis EN Tangie, SA Vickers, BH Chendi, T Jooste, TN Mann, JH Davis, ... BMJ Global Health 8 (Suppl 10), 2023 | | 2023 |
Host biosignatures as diagnostic tools for Tuberculosis in low and high endemic regions BH Chendi | | 2022 |